Accrol Group Holdings plc Finish FY19 in a much stronger position

Accrol Group Holdings plc
[shareaholic app="share_buttons" id_name="post_below_content"]

The Board of Accrol Group Holdings plc (LON: ACRL) has today announced the following trading update ahead of its results for the full year ended 30 April 2019, which will be announced on 3 September 2019.

Following the conclusion of the restructuring, the Group performed well in Q4 and in line with the management’s strategic turnaround objectives, achieving and maintaining acceptable levels of monthly profitability on an Adjusted EBITDA level.

Total revenues in FY19 were c.£119 million, broadly unchanged on a like for like basis against the prior year, as the Group exited a number of low margin contracts. Sales in the Group’s core toilet roll product, however, increased by c.12% year on year to c.£85 million from £76 million in FY18. Adjusted EBITDA was c.£1 million, representing a c.£7 million improvement on the prior year despite the substantial impact of FX and material cost headwinds which increased by an estimated c.£10 million. Adjusted loss before tax is expected to be in the range of £2.5 million to £3.0 million. Exceptional costs, primarily associated with the turnaround process, are expected to be in the range of £7.5 million to £8.0 million. Net debt was reduced faster than anticipated, finishing the year at c.£27.1 million, c.£2.5 million lower than the previously anticipated level of c.£29.6 million, ensuring that the Group comfortably fulfilled on its banking commitments.

Dan Wright, Chairman of Accrol Group Holdings plc , said:

“I am very pleased to report that we finished FY19 in a much stronger position, following the conclusion of a transformational restructuring, and that the new financial year has started well. The Group is now enjoying the full benefits of the structural cost savings achieved in FY19, achieving an acceptable level of margin for a business of its type. Our management team is confident of delivering further profitable revenue growth and creating new exciting opportunities for the Group. I look forward to reporting further details of our progress when we announce the Final Results in September.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.
Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.
In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap
Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Search

Search